Schorlemmer H U, Hofstaetter T, Seiler F R
Behring Inst Mitt. 1984 Nov(76):88-97.
Human neutrophils and peripheral blood monocytes were studied for their Fc- and C3b-receptors after incubation of the cells with two types of immune complexes (IgG or F(ab')2. Immune complexes can bind to and activate phagocytes via Fc- and C3b-receptors. On mononuclear phagocytes an additional receptor is found that is able to interact directly with F(ab')2-complexes. C3b- and Fc-receptors can mediate ingestion of appropriately opsonized particles, C3b-receptors being at least as efficient as Fc-receptors. The extents of cell activation and phagocytosis in vitro depend on a number of variables, like complex size, ligand (antibody, C3b) density on the surface of opsonized particles, receptor number etc., which are not controlled in most studies and thus may explain the discrepant results reported in the literature. With the in vitro results obtained here, we cannot fully explain in vivo data obtained by various groups, where F(ab')2 antibodies yielded full protection against different types of infections. Therefore, great caution must be applied in all attempts to extrapolate in vitro data to the actual situation in vivo.
在用两种类型的免疫复合物(IgG 或 F(ab')₂)孵育细胞后,研究了人类中性粒细胞和外周血单核细胞的 Fc 受体和 C3b 受体。免疫复合物可通过 Fc 受体和 C3b 受体结合并激活吞噬细胞。在单核吞噬细胞上发现了一种额外的受体,它能够直接与 F(ab')₂复合物相互作用。C3b 受体和 Fc 受体可介导对适当调理颗粒的摄取,C3b 受体至少与 Fc 受体一样有效。体外细胞激活和吞噬的程度取决于许多变量,如复合物大小、调理颗粒表面的配体(抗体、C3b)密度、受体数量等,在大多数研究中这些变量并未得到控制,因此这可能解释了文献中报道的相互矛盾的结果。根据此处获得的体外结果,我们无法完全解释各研究小组获得的体内数据,其中 F(ab')₂抗体对不同类型的感染提供了完全保护。因此,在所有将体外数据外推至体内实际情况的尝试中都必须极其谨慎。